Cabaletta Historical Income Statement
CABA Stock | USD 2.91 0.20 6.43% |
Historical analysis of Cabaletta Bio income statement accounts such as Selling General Administrative of 10.9 M, Research Development of 58.2 M or Total Operating Expenses of 78.4 M can show how well Cabaletta Bio performed in making a profits. Evaluating Cabaletta Bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cabaletta Bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Cabaletta Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cabaletta Bio is a good buy for the upcoming year.
Cabaletta |
About Cabaletta Income Statement Analysis
Cabaletta Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cabaletta Bio shareholders. The income statement also shows Cabaletta investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Cabaletta Bio Income Statement Chart
Add Fundamental
Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Cabaletta Bio. It is also known as Cabaletta Bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Cabaletta Bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cabaletta Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.At present, Cabaletta Bio's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Research Development is expected to grow to about 58.2 M, whereas Selling General Administrative is forecasted to decline to about 10.9 M.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 46.3M | 54.1M | 74.7M | 78.4M | Research Development | 32.5M | 39.3M | 55.4M | 58.2M |
Cabaletta Bio income statement Correlations
Click cells to compare fundamentals
Cabaletta Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cabaletta Bio income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Selling General Administrative | 7.0M | 12.5M | 13.8M | 14.8M | 19.2M | 10.9M | |
Operating Income | (18.7M) | (33.8M) | (46.3M) | (54.1M) | (74.7M) | (70.9M) | |
Net Income From Continuing Ops | (16.9M) | (33.3M) | (46.3M) | (53.0M) | (67.7M) | (64.3M) | |
Ebit | (18.7M) | (33.8M) | (46.3M) | (54.1M) | (74.7M) | (70.9M) | |
Research Development | 11.7M | 21.4M | 32.5M | 39.3M | 55.4M | 58.2M | |
Total Operating Expenses | 18.7M | 33.8M | 46.3M | 54.1M | 74.7M | 78.4M | |
Income Before Tax | (16.9M) | (33.3M) | (46.3M) | (53.0M) | (67.7M) | (64.3M) | |
Net Income Applicable To Common Shares | (22.3M) | (33.3M) | (46.3M) | (53.0M) | (47.7M) | (45.3M) | |
Net Income | (15.1M) | (32.5M) | (45.5M) | (51.8M) | (67.7M) | (64.3M) | |
Net Interest Income | 1.7M | 494K | 24K | 1.2M | 7.0M | 7.3M | |
Interest Income | 1.7M | 494K | 24K | 1.2M | 7.0M | 7.3M | |
Depreciation And Amortization | 104K | 354K | 733K | 1.2M | 1.4M | 1.5M | |
Other Operating Expenses | 18.7M | 33.8M | 46.3M | 54.1M | 74.7M | 42.9M | |
Ebitda | (18.6M) | (33.5M) | (45.6M) | (53.0M) | (73.2M) | (69.6M) | |
Total Other Income Expense Net | 1.7M | 494K | 24K | 1.2M | 7.0M | 7.3M | |
Income Tax Expense | (1.8M) | (848K) | (757K) | (1.2M) | (1.0M) | (1.1M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.16) | Return On Assets (0.31) | Return On Equity (0.48) |
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.